Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Holist Nurs Pract. 2013 Nov-Dec;27(6):336–343. doi: 10.1097/HNP.0b013e3182a72ca4

TABLE 3.

Mean Monthly Blood Pressure and Stress Scoresa

Group Pretreatment,
mean
(SD), mm
Hg
Month 1,
mean
(SD),
mm Hg
Month 2,
mean
(SD),
mm Hg
Month 3,
mean
(SD), mm
Hg
Mean Diff,

mm Hg
Experimental (1E)
  SBPb (12.45) 127.17 122.84 (14.58) 124.15 (13.31) 122.11 (11.83) 5.06
  DBPb (8.04) 78.63 75.71 (7.93) 76.78 (9.71) 74.95 (7.65) 3.67
  Stressc (0.76) 2.79 2.53 (0.60) 2.91 (0.73) 2.72 (0.64) 0.07
Control (2C)
  SBPb (12.34) 130.84 126.74 (10.75) 125.03 (10.64) 126.51 (9.97) 4.34
  DBPb (9.24) 77.22 75.69 (7.76) 75.62 (9.16) 75.97 (9.07) 1.24
  Stressc (0.79) 2.72 2.57 (0.70) 2.48 (0.53) 2.38 (0.60) 0.34
Delayed experimental (2DE)d
  SBP (13.29) 130.81 126.29 (6.43) 125.45 (9.60) 126.92 (8.66) 3.88
  DBP (10.51) 76.39 75.70 (9.12) 75.75 (10.79) 76.53 (9.78) − 0.14
  Stress (0.86) 2.62 2.28 (0.55) 2.35 (0.78) 2.35 (0.76) 0.25

Abbreviations: DBP, diastolic blood pressure; Mean Diff, mean difference between pretreatment scores and month 3 (Mpretreatment − Mmonth3 = M Diff); SBP, systolic blood pressure.

a

Means do not differ significantly between initial treatment and control groups.

b

Participants were included if they submitted at least 2 BP scores/month (n = 18).

c

Participants were included if they submitted at least 2 BP scores and 2 stress scores per month (n = 15).

d

Participants only included if they completed delay treatment paradigm (n = 12).